In this webinar, Dr. Michael Rafii joins the National Down Syndrome Society (NDSS) to discuss the latest understanding of Alzheimer’s disease, recent advances in diagnostic tests and treatments for Alzheimer’s disease in the general population, and why individuals with Down syndrome are at high risk for developing Alzheimer’s disease. He also discusses efforts aimed at bringing these new diagnostic tests and treatments to benefit the Down syndrome community.